Clinical trial
Tirzepatide in Obesity-Driven Endometrial Cancer
NCT07065552
Study timeline
Study start (actual)2026-04-27Date precision: day
Registry last updated2026-10-02
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Endometrial Cancerunresolved
Obesityunresolved
Interventions
TirzepatideDRUG · verified · RxNorm: tirzepatide
Sponsors & collaborators
UNC Lineberger Comprehensive Cancer Centerlead sponsor
United States Department of Defensecollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT07065552 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.